Viking Therapeutics Reports Third Quarter 2016 Financial Results and Provides Corporate Update
Go back to Viking Therapeutics Reports Third Quarter 2016 Financial Results and Provides Corporate Update| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 29.86 +0.34 (1.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.52 | 52 Week High | $5.17 | |||
| Open | $30.24 | 52 Week Low | $0.94 | |||
| Day High | $30.54 | P/E | N/A | |||
| Day Low | $29.86 | EPS | $0.00 | |||
| Volume | 664,651 | |||||
